Para brindar el contenido más relevante a los lectores de HealthCare Business News, le pedimos que comparta un poco de información sobre quién es usted (tarda dos segundos y listo).
Registro
GE's Invenia ABUS increases dense breast cancer detection by 57 percent
The system received FDA approval in 2014. That year, Dr. Monica Saini, a radiologist at Santa Fe Imaging, told Forbes that the system appealed to her patients in some ways that mammo and 3-D mammo didn't. âIn Santa Fe thereâs a lot of concern about radiation,â she said. âAfter speaking with many patients, we realized that many were more amenable to an extra ultrasound exam than to tomosynthesis."
She and four colleagues in the Santa Fe practice began using the ABUS system in July 2014. âMost patients have liked it,â she said. âItâs nice because thereâs no compression, as with mammography.â
The following video from 2014 offers an overview of how the system works.
While it remains to be seen how ABUS will change breast cancer screening protocols and if it is cost effective, Wilczek is enthusiastic about the findings. "If, as a woman to be screened, I would be offered ABUS I would not hesitate to accept the examination," she said.